Why the study?
LGE-CMR requires novel and time-efficient approaches to characterize the myocardial substrate associated with ventricular arrhythmia in patients with ischemic cardiomyopathy.
Does 3D-upsampled transmural scar assessment from 2D LGE-CMR images improve the characterization of myocardial substrate associated with VT features and recurrences compared to conventional 2D assessment in ischemic cardiomyopathy?
Population
Pigs and patients with established myocardial infarction
Comparison
3D-upsampled models from 2D LGE-CMR images vs 3D-acquired sequences and conventional 2D assessment
Design
Translational validation study
Key result
Transmural scar assessment using 3D-upsampled models from 2D LGE-CMR images revealed that patients with ventricular tachycardia recurrences had significantly lower scar areas compared to those without recurrences (64.0 vs 83.0 cm2, p=0.04).
Authors
Loading...
Questions scar burden as VT recurrence predictor; leaves open validation of 3D-upsampled LGE-CMR models.
Cohort (n=14)
Yes
Does 3D-upsampled transmural scar assessment from 2D LGE-CMR images improve the characterization of myocardial substrate associated with VT features and recurrences compared to conventional 2D assessment in ischemic cardiomyopathy?
Absolute Event Rate: 64% vs 83%
p-value: p=0.04
A novel 3D-upsampled methodology from standard 2D LGE-CMR images provides a time-efficient and superior alternative to conventional 2D assessment for characterizing arrhythmogenic scar substrate and predicting VT recurrences in ischemic cardiomyopathy.
Merino‐Caviedes et al. (2021) conducted a cohort in Ischemic cardiomyopathy with spontaneous ventricular tachycardia (n=14). 3D-upsampled models from 2D LGE-CMR images vs. Conventional 2D LGE-CMR assessment was evaluated on Scar area on 3D-upsampled models (transmurality < 0.2) in patients with vs without VT recurrences (p=0.04). Transmural scar assessment using 3D-upsampled models from 2D LGE-CMR images revealed that patients with ventricular tachycardia recurrences had significantly lower scar areas compared to those without recurrences (64.0 vs 83.0 cm2, p=0.04).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: